SMAD2 and gastric cancer: In the HER2-positive gastric cancer cases, the co-expression of p-Smad2/c-Met was significantly correlated with the pathological stage (p = 0.042) and tended to be correlated with the T stage (p = 0.104) and N stage (p = 0.098).